Preconception hypoglycemia is linked to increased risks of preterm birth, low birth weight, and birth defects, a new study from China finds.
Study finds preconception hypoglycemia tied to adverse pregnancy outcomes | Image Credit: © fotoduets - stock.adobe.com.
Women with low blood glucose levels prior to pregnancy may face a higher risk of adverse pregnancy outcomes, according to findings from a large retrospective study published July 29 in PLOS Medicine.1,2
Researchers analyzed data from nearly 4.9 million Chinese women and found that preconception hypoglycemia was associated with an increased risk of preterm birth, low birth weight, small for gestational age, and birth defects—even in women without pre-existing diabetes.
The study, led by Hanbin Wu of the Chinese University of Hong Kong in collaboration with China’s National Research Institute for Family Planning, evaluated participants in the National Free Preconception Checkup Project between 2013 and 2016. All women were aged 20 to 49 years and conceived within one year of enrollment.
Of the total study population, 239,128 women (4.91%) had fasting plasma glucose (FPG) levels below 3.9 mmol/L at the preconception visit, classifying them as hypoglycemic per American Diabetes Association criteria.
Compared with women with normal FPG levels (3.9–<5.6 mmol/L), those with hypoglycemia were generally younger, more likely to be underweight, and had a higher prevalence of anemia. The adjusted analyses accounted for a broad range of confounders, including maternal age, BMI, parity, region, smoking status, chronic disease, and prior adverse pregnancy history.
Women with preconception hypoglycemia had significantly higher odds of several outcomes:
However, hypoglycemia was also linked to a modest reduction in several outcomes:
Outcomes were consistent across multiple sensitivity analyses, including those excluding women with prior adverse pregnancy outcomes or diabetes diagnoses.
The researchers also assessed the interaction between preconception BMI and hypoglycemia. Among underweight women, hypoglycemia was associated with a higher risk of miscarriage or early stillbirth. In contrast, overweight women with hypoglycemia showed a reduced risk of macrosomia and large-for-gestational-age infants.
“In addition to paying attention to women with preconception hyperglycemia, our findings call for increased concern for women with hypoglycemia in preconception glycemic screening,” the authors wrote. “These findings emphasize the importance of preconception examination in preventing and managing reproductive health risks for all women planning to conceive.”
The study has several limitations. It included only Chinese women, which may limit generalizability, and relied on a single fasting glucose measurement without HbA1c data. The authors also noted the potential for unmeasured confounding factors, such as gestational complications or post-screening interventions.
Still, the authors suggest that these findings support the potential benefit of adding hypoglycemia screening to preconception care. “Comprehensive screening and coordinated interventions for abnormal FPG prior to and during pregnancy… is crucial for advancing the intervention window and mitigating the risk of adverse pregnancy outcomes,” they wrote.
References:
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
S4E1: New RNA platform can predict pregnancy complications
August 1st 2025In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen